Brief: RTW Biotech Opportunities Ltd Says Novartis To Acquire Avidity Biosciences

RTW Biotech Opportunities

27/10/2025 07:32

Oct 27 (Reuters) - RTW Biotech Opportunities Ltd RTW.L:

RTW BIOTECH OPP.  - NOVARTIS TO ACQUIRE AVIDITY BIOSCIENCES

RTW BIOTECH OPPORTUNITIES LTD - AVIDITY TO BE BOUGHT FOR $72 PER SHARE, VALUED AT $12 BILLION

Source text: ID:nRSa8527Ea

Further company coverage: RTW.L

 ((Reuters.Briefs@thomsonreuters.com;))